Folgen
David B. Seifer
David B. Seifer
Yale School of Medicine - Professor of Ob,Gyn & Reproductive Sciences
Bestätigte E-Mail-Adresse bei yale.edu
Titel
Zitiert von
Zitiert von
Jahr
Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles
DB Seifer, DT MacLaughlin, BP Christian, B Feng, RM Shelden
Fertility and sterility 77 (3), 468-471, 2002
6442002
Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome
DB Seifer, G Lambert-Messerlian, JW Hogan, AC Gárdiner, AS Blazar, ...
Fertility and sterility 67 (1), 110-114, 1997
5151997
Ovarian reserve testing: a user’s guide
R Tal, DB Seifer
American journal of obstetrics and gynecology 217 (2), 129-140, 2017
4692017
Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating …
A Hazout, P Bouchard, DB Seifer, P Aussage, AM Junca, P Cohen-Bacrie
Fertility and sterility 82 (5), 1323-1329, 2004
4332004
Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States
DB Seifer, VL Baker, B Leader
Fertility and sterility 95 (2), 747-750, 2011
3892011
Laparoscopy in 100 women with chronic pelvic pain
AJ Kresch, DB Seifer, LB Sachs, I Barrese
Obstetrics & Gynecology 64 (5), 672-674, 1984
3751984
Environmental toxicants and female reproduction
FI Sharara, DB Seifer, JA Flaws
Fertility and sterility 70 (4), 613-622, 1998
3611998
Assessing ovarian response: antral follicle count versus anti-Müllerian hormone
R Fleming, DB Seifer, JL Frattarelli, J Ruman
Reproductive biomedicine online 31 (4), 486-496, 2015
3032015
Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance
DB Seifer, DT MacLaughlin
Fertility and sterility 88 (3), 539-546, 2007
2872007
Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors
CA Dahl Lyons, CA Wheeler, GN Frishman, RJ Hackett, DB Seifer, ...
Human Reproduction 9 (5), 792-799, 1994
2711994
Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone
DB Seifer, RT Scott Jr, PA Bergh, LK Abrogast, CI Friedman, CK Mack, ...
Fertility and sterility 72 (1), 63-65, 1999
2681999
Müllerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology
T Silberstein, DT MacLaughlin, I Shai, JR Trimarchi, ...
Human Reproduction 21 (1), 159-163, 2006
2632006
Dimeric inhibin: a direct marker of ovarian aging
DR Danforth, LK Arbogast, J Mroueh, MH Kim, EA Kennard, DB Seifer, ...
Fertility and sterility 70 (1), 119-123, 1998
2391998
The detection of diminished ovarian reserve in infertile women
FI Sharara, RT Scott Jr, DB Seifer
American journal of obstetrics and gynecology 179 (3), 804-812, 1998
2341998
Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis
R Tal, O Tal, BJ Seifer, DB Seifer
Fertility and sterility 103 (1), 119-130. e3, 2015
2222015
Variations in serum müllerian inhibiting substance between white, black, and Hispanic women
DB Seifer, ET Golub, G Lambert-Messerlian, L Benning, K Anastos, ...
Fertility and sterility 92 (5), 1674-1678, 2009
2002009
Vitamin D increases serum levels of the soluble receptor for advanced glycation end products in women with PCOS
M Irani, H Minkoff, DB Seifer, Z Merhi
The Journal of Clinical Endocrinology & Metabolism 99 (5), E886-E890, 2014
1952014
Circulating vitamin D correlates with serum antimüllerian hormone levels in late-reproductive-aged women: Women's Interagency HIV Study
ZO Merhi, DB Seifer, J Weedon, O Adeyemi, S Holman, K Anastos, ...
Fertility and sterility 98 (1), 228-234, 2012
1932012
Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology …
R Tal, DB Seifer, M Khanimov, HE Malter, RV Grazi, B Leader
American journal of obstetrics and gynecology 211 (1), 59. e1-59. e8, 2014
1802014
Maternal and neonatal morbidity associated with in vitro fertilization
CP Tallo, B Vohr, W Oh, LP Rubin, DB Seifer, RV Haning Jr
The Journal of pediatrics 127 (5), 794-800, 1995
1611995
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20